Clinical Trials Insight: 700030750

Trial Profile

Clinical Trials Insight: 700030750

Phase of Trial: Phase II

Latest Information Update: 02 Dec 2008

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting; Nausea and vomiting; Radiotherapy-induced nausea and vomiting
  • Focus Pharmacokinetics
  • Sponsors MonoSol Rx; Par Specialty Pharmaceuticals
  • Most Recent Events

    • 02 Dec 2008 New source identified and integrated (media release from Strativa)
    • 25 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top